Cancer evolution study reveals biology of glioma progression

A signifier of glioma, a benignant of encephalon cancer, tends to advancement toward greater malignancy owed to an expanding inclination of glioma cells to alteration into immature, stem cell-like states, according to a survey led by investigators astatine Weill Cornell Medicine, the New York Genome Center, Harvard Medical School and Mass General Brigham. The findings showcase the powerfulness of modern laboratory exertion for illuminating crab improvement and could pass aboriginal treatments and prognostic measures for gliomas.